Director Marc L. Andreessen has reduced his indirect stake in Samsara Inc. (NASDAQ:IOT) through a series of substantial stock sales, according to regulatory filings. The transactions, disclosed via Form 4 submissions to the Securities and Exchange Commission, spanned two consecutive days in mid-June 2026. Andreessen disposed of a combined 1,113,660 shares of Samsara Class A Common Stock, generating proceeds of approximately $36.6 million.
The sales were executed through the LAMA Community Trust, an entity in which Andreessen serves as trustee. On June 10, 2026, the initial tranche involved the sale of 500,000 shares. This portion was split into two distinct blocks: 168,806 shares were transacted at a weighted-average price of $32.8286, with individual prices fluctuating between $32.48 and $33.44. The remaining 331,194 shares were sold at a higher weighted-average price of $34.1094, with individual transaction values ranging from $33.53 to $34.37.
Trading activity continued the following day, June 11, 2026, with Andreessen disposing of an additional 613,660 shares. This second batch included 468,751 shares sold at a weighted-average price of $32.1791, with individual prices ranging from $31.50 to $32.49. A further 144,909 shares were sold at a weighted-average price of $32.5575, with individual prices ranging from $32.50 to $32.81. Following these dispositions, Andreessen retains an indirect holding of 2,256,487 shares in Samsara Class A Common Stock.
The insider activity unfolds against a backdrop of strong operational performance for Samsara. The company reported a gross profit margin of 76.3% and achieved revenue growth of 29.6% over the last twelve months. Samsara's stock currently trades at $33.66, reflecting a market capitalization of $18.8 billion. Despite these robust metrics, data from InvestingPro analysis suggests the stock may be trading above its fair value estimate, placing it among companies categorized as overvalued.
Market sentiment remains largely positive following Samsara's first-quarter fiscal 2027 earnings report. The company posted earnings per share of $0.17, surpassing the consensus forecast of $0.13. Revenue came in at $478.8 million, exceeding expectations of $455.2 million. This performance prompted several analyst firms to adjust their outlooks. Wolfe Research reaffirmed its Outperform rating and set a new price target of $50.00, citing confidence in the company's growth pipeline after meeting with the CFO. Piper Sandler increased its price target to $40 from $39, maintaining an Overweight rating and highlighting the company's results and raised guidance. Similarly, RBC Capital raised its price target to $42 from $41, pointing to the company's 30% annual recurring revenue growth and momentum with large customers.